NHS partners with pharma giant to trial a twice-a-year jab to lower cholesterol levels

NHS partners with pharma giant to trial a twice-a-year jab to lower cholesterol levels

NHS partners with pharma giant to trial a twice-a-year jab to lower cholesterol levels

Cardiovascular disease, including heart disease and stroke, are among the top killers worldwide. Ischemic heart disease and stroke are the world’s major killers, accounting for 15.2 million deaths in 2016. A high triglyceride level, combined with high low-density lipoprotein (LDL) cholesterol, is linked to atherosclerosis, which increases the risk for heart attack and stroke.